TNSN98138A1 - Nouveaux derives benzamides stimulants de la motricite gastrointestinale haute et basse - Google Patents

Nouveaux derives benzamides stimulants de la motricite gastrointestinale haute et basse

Info

Publication number
TNSN98138A1
TNSN98138A1 TNTNSN98138A TNSN98138A TNSN98138A1 TN SN98138 A1 TNSN98138 A1 TN SN98138A1 TN TNSN98138 A TNTNSN98138 A TN TNSN98138A TN SN98138 A TNSN98138 A TN SN98138A TN SN98138 A1 TNSN98138 A1 TN SN98138A1
Authority
TN
Tunisia
Prior art keywords
motority
benzamide derivatives
low gastrointestinal
stimulating
novel
Prior art date
Application number
TNTNSN98138A
Other languages
English (en)
Inventor
Thierry Bouyssou
Helene Christinaki
Olivier Boucheix
Serge Boisa
Christian Jeanpetit
Original Assignee
Logeais Labor Jacques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Logeais Labor Jacques filed Critical Logeais Labor Jacques
Publication of TNSN98138A1 publication Critical patent/TNSN98138A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L'INVENTION CONCERNE DES COMPOSES DE FORMULE GENERALE (I) SUIVANTE :DANS LAQUELLE n = 1 OU 2, R1 EST UN GROUPE ALKYLE OU CYCLOALKYLE, R2 ET R3 REPRESENTENT H, OH, OU UN GROUPE CYCLOALKYLE. L'INVENTION CONCERNE EGALEMENT LES COMPOSITIONS PHARMACEUTIQUES CONTENANT CES COMPOSES, ET LEUR UTILISATION DANS LE CADRE DU TRAITEMENT DES DYSFONCTIONNEMENTS DU TUBE DIGESTIF HAUT ET BAS
TNTNSN98138A 1997-07-25 1998-07-15 Nouveaux derives benzamides stimulants de la motricite gastrointestinale haute et basse TNSN98138A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9709477A FR2766484B1 (fr) 1997-07-25 1997-07-25 Nouveaux derives benzamides stimulants de la motricite gastrointestinale haute et basse

Publications (1)

Publication Number Publication Date
TNSN98138A1 true TNSN98138A1 (fr) 2005-03-15

Family

ID=9509623

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN98138A TNSN98138A1 (fr) 1997-07-25 1998-07-15 Nouveaux derives benzamides stimulants de la motricite gastrointestinale haute et basse

Country Status (8)

Country Link
EP (1) EP0998458A1 (fr)
AR (1) AR014900A1 (fr)
AU (1) AU8867898A (fr)
CO (1) CO4990994A1 (fr)
FR (1) FR2766484B1 (fr)
TN (1) TNSN98138A1 (fr)
WO (1) WO1999005106A1 (fr)
ZA (1) ZA986633B (fr)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE620543A (fr) *
GB1015921A (en) * 1961-10-06 1966-01-05 Benger Lab Ltd Benzamides
AR216043A1 (es) * 1974-03-21 1979-11-30 Anphar Sa Procedimiento para la preparacion de 1-derivados de benzoilamino-4-piperidina y sus sales fisiologicamente aceptables
WO1987002584A1 (fr) * 1985-10-25 1987-05-07 The Upjohn Company Anti-convulsifs a l'acetamide et a la benzamide de cis-n-(2-aminocycloaliphatique)benzene
FR2674849B1 (fr) * 1991-04-02 1994-12-23 Logeais Labor Jacques Nouveaux derives de n-cyclohexyl benzamides ou thiobenzamides, leurs preparations et leurs applications en therapeutique.
WO1993003725A1 (fr) * 1991-08-20 1993-03-04 Smithkline Beecham Plc Antagonistes du recepteur 5-ht4
AU2075295A (en) * 1994-03-14 1995-10-03 Sanofi Use of 4-amino-5-chloro-2-methoxybenzoic esters as 5-ht4 agonists
FR2735693B1 (fr) * 1995-06-23 1997-09-26 Logeais Labor Jacques Nouvelles applications therapeutiques de n-cyclohexyl benzamides

Also Published As

Publication number Publication date
AU8867898A (en) 1999-02-16
FR2766484A1 (fr) 1999-01-29
FR2766484B1 (fr) 1999-09-17
CO4990994A1 (es) 2000-12-26
WO1999005106A8 (fr) 1999-04-15
EP0998458A1 (fr) 2000-05-10
ZA986633B (en) 1999-06-15
AR014900A1 (es) 2001-04-11
WO1999005106A1 (fr) 1999-02-04

Similar Documents

Publication Publication Date Title
FR2430410A1 (fr) Phenethanolamines et compositions pharmaceutiques en contenant
TNSN96161A1 (fr) Derives de la quinoleine et de quinazoline nouveaux procede pour leur preparation et formulations pharmaceutiques les contenant.
NO170280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfamatderivater
DE59109082D1 (de) Mono-N-substituierte 1,4,7,10-Tetraazacyclododecan-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
FR2435471A1 (fr) Derives de dihydropyridine, procedes d'obtention et compositions pharmaceutiques en contenant
NZ240189A (en) Aryl substituted amides, carbamates, carbonates, ketones and esters; preparation and pharmaceutical/cosmetic compositions thereof
TNSN96085A1 (fr) Amides therapeutiques et compositions les contenant
NZ236589A (en) A-nor-steroid-3-carboxylic acid derivatives and pharmaceutical compositions
ES480850A1 (es) Procedimiento para preparar hidantoinas.
ATE60759T1 (de) Bisdimethoxymethyl(trimethoxybenzyl)isochinolinium salze, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
FR2354091A1 (fr) Utilisation d'esters aliphatiques d'acide 2-methyl-2-alkylalcanoiques comme matieres aromatiques et compositions de parfums en contenant
ES8207169A1 (es) Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad.
TNSN98210A1 (fr) Trifluoromethylethers cycliques a fonction piperidinylaminomethyle, procede pour leur preparation et compositions pharmaceutiques les contenant
ATE41772T1 (de) Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
ATE18549T1 (de) 1-carboxyalkanoylindolin-2-carbonsaeure-ester, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
FR2445329A1 (fr) Derives du 11-bromo-14-oxo-15-hydroxy-imino-e-homo-eburnane, leur preparation et leur utilisation comme medicament
CA2107485A1 (fr) Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2707089B1 (fr) Nouveaux dérivés d'acide phosphonique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
OA09349A (fr) "Nouveaux dérivés du 3-aminochromane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent".
TNSN98138A1 (fr) Nouveaux derives benzamides stimulants de la motricite gastrointestinale haute et basse
BE878020A (fr) Derives n-substitues de l'acide aziridine-2-carboxylique immunostimulateurs, procedes de preparation et compositions pharmaceutiques les contenant
FR2421613A1 (fr) Compositions contenant des benzamides de 3-aminopyrrolidines et leur utilisation therapeutique pour le traitement des allergies
OA09665A (fr) Esters d'aminoacides de l'hydroquinone, leur procédé de préparation et compositions pharmaceutiques ou cosmétiques les contenant
ATE7224T1 (de) Propanolamin-derivate, ihre salze, verfahren zu ihrer herstellung und pharmazeutische praeparate.
BE1002181A3 (fr) 3-(2-haloalkyl)-1,4-oxathiines et 2-(2-haloalkyl)-1,4-dithiines, de meme que le traitement de la leucemie et des tumeurs avec ces substances.